The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumorsLauren L Campbell Marotta, Kornélia Polyák, Sibgat Choudhury et al.|Journal of Clinical Investigation|2011Cited by 928
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Aviv Regev, Itay Tirosh et al.|Nature Medicine|2020Cited by 522
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101
Targeting constitutively active <scp>STAT3</scp> in chronic lymphocytic leukemia: A clinical trial of the <scp>STAT3</scp> inhibitor pyrimethamine with pharmacodynamic analysesJennifer R. Brown, David A. Frank, Sarah R. Walker et al.|American Journal of Hematology|2020Cited by 29